Exploratory Measurement Science
ID: 7Type: Phase I
Overview

Topic

Exploratory Measurement Science

Agency

Department of CommerceNational Institute of Standards and Technology

Program

Type: SBIRPhase: Phase IYear: 2024

Topic Link

https://www.sbir.gov/node/2474019

Additional Information

https://www.nist.gov/tpo/small-business-innovation-research-program-sbir
Timeline
  1. 1
    Release Oct 24, 2023 12:00 AM
  2. 2
    Open Oct 24, 2023 12:00 AM
  3. 3
    Next Submission Due Dec 22, 2023 12:00 AM
  4. 4
    Close Dec 22, 2023 12:00 AM
Description

The Department of Commerce's National Institute of Standards and Technology (NIST) is seeking proposals for the NIST FY 2024 Small Business Innovation Research (SBIR) Phase I program. The specific topic of the solicitation is "Exploratory Measurement Science".

This solicitation is focused on research in the field of measurement science and aims to support innovative projects that explore new measurement techniques, methods, or technologies. The goal is to advance the accuracy, reliability, and efficiency of measurements in various industries and applications.

The potential impacts of the technology or research funded through this program include improved measurement capabilities, enhanced product quality, increased manufacturing efficiency, and better understanding of physical phenomena. The research outcomes can have broad applications across industries such as healthcare, manufacturing, energy, and environmental monitoring.

The Phase I program provides funding for feasibility studies and proof-of-concept research. The project duration is typically six months, and successful Phase I awardees may be eligible for Phase II funding to further develop and commercialize their technology.

Interested applicants can find more information and submit their proposals through the NIST SBIR program website. The solicitation is currently closed, and the application due date was December 22, 2023.

For more details, please refer to the NIST FY 2024 Small Business Innovation Research (SBIR) Phase I NOFO document available at grants.gov.

Files
No associated files provided.
Similar Opportunities
NINDS Exploratory Clinical Trials for Small Business (R43/R44 Clinical Trial Required)
Active
Department of Health and Human Services
The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for the NINDS Exploratory Clinical Trials for Small Business (R43/R44 Clinical Trial Required) topic. This solicitation aims to support small business concerns (SBCs) in conducting exploratory clinical trials that contribute to the justification for future trials to establish definitive efficacy. The trials can include Phase 1 and 2 studies of drugs and biologics, feasibility and preliminary efficacy studies of devices, as well as early studies of surgical, behavioral, or rehabilitation therapies. The trials can be single-site or multi-site with up to three clinical sites. The applications must generate data that inform further clinical development of the proposed intervention or diagnostic, and FDA approval is required for FDA-regulated clinical trials. The goal is to advance products/technologies that require federal regulatory approval or bring complex research tools to market. The solicitation is open until September 6, 2026, and more information can be found at the provided links.
NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required)
Active
Department of Health and Human Services
The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for the NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required). This solicitation aims to support small business concerns (SBCs) in conducting exploratory clinical trials that contribute to the justification for future trials to establish definitive efficacy. The trials can include Phase 1 and 2 studies of drugs and biologics, feasibility and preliminary efficacy studies of devices, as well as early studies of surgical, behavioral, or rehabilitation therapies. The trials can be single-site or multi-site with up to three clinical sites. The applications must generate data that inform further clinical development of the proposed intervention or diagnostic, and FDA approval is required for FDA-regulated clinical trials. The goal is to advance products/technologies that require federal regulatory approval or bring complex research tools to market. The funding opportunity is open until September 6, 2026. For more information and to apply, visit the solicitation agency URL: [link](https://grants.nih.gov/grants/guide/pa-files/PAR-24-044.html).
NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required)
Active
Department of Health and Human Services
The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for the NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required). This solicitation aims to support small business concerns (SBCs) in conducting exploratory clinical trials that contribute to the justification for future trials to establish definitive efficacy. The trials can include Phase 1 and 2 studies of drugs and biologics, feasibility and preliminary efficacy studies of devices, as well as early studies of surgical, behavioral, or rehabilitation therapies. The trials can be single-site or multi-site with up to three clinical sites. The applications must generate data that inform further clinical development of the proposed intervention or diagnostic, and FDA approval is required for FDA-regulated clinical trials. The goal is to advance products/technologies that require federal regulatory approval or bring complex research tools to market. The funding opportunity is open until September 6, 2026. For more information and to apply, visit the solicitation agency URL: [link](https://grants.nih.gov/grants/guide/pa-files/PAR-24-044.html).
NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44 Clinical Trial Required)
Active
Department of Health and Human Services
The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for the NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44 Clinical Trial Required). This solicitation encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to implement investigator-initiated clinical trials, including mechanistic studies associated with clinical trials. The program supports milestone-driven, hypothesis-driven clinical trials related to the research mission of the NIAID that address high-priority research areas. The solicitation encourages high-risk clinical studies, which involve non-routine interventions, administration of unlicensed products, or administration of licensed products for unapproved indications. Mechanistic studies are also encouraged. The funding supports the conduct, completion, and analysis of a single clinical trial, including activities such as training of study personnel, enrollment and recruitment of study subjects, data collection and management, laboratory work, study management and oversight, safety monitoring, and regulatory activities. The project duration is not specified, but the solicitation is open until January 14, 2027. The funding specifics can be found on the grants.nih.gov website.
DOD STTR 24.D Annual - Optical-Atomic System Integration & Calibration (OASIC)
Active
Department of Defense
The Department of Defense (DOD) is seeking proposals for the topic of "Optical-Atomic System Integration & Calibration (OASIC)" as part of the Small Business Innovation Research (SBIR) program. The objective is to create a user facility for an atom-based quantum testbed that can prototype, validate, and benchmark nanophotonic, optoelectronic, and electronic components and sub-systems. The goal is to enable the development of scalable, low-SWaP atom-based quantum sensors, clocks, computing architectures, and other integrated or chip-scale quantum technologies. The solicitation emphasizes the need for rigorous testing and evaluation procedures compatible with the performance requirements of atom-based quantum devices. The Phase I of the project will focus on designing and analyzing the performance and operation of the proposed testbed user facility, as well as developing an operation and business plan. The Phase II will involve constructing and demonstrating the quantum testbed based on the Phase I design. The project duration for Phase I is 4 months, and for Phase II is 24 months. The solicitation encourages the development of integrated, low-SWaP quantum systems for applications in defense and commercial markets. The deadline for proposal submission is March 31, 2025. For more information, visit the [solicitation link](https://www.sbir.gov/node/2506137).